Showing 1441-1450 of 1581 results for "".
- Demystified: Your Insurance Coverage During COVID-19https://modernaesthetics.com/news/demystified-your-insurance-coverage-during-covid-19/2472913/Jason O’Dell, a financial consultant and insurance specialist at OJM Group, spoke with New Jersey-based dermatologist Jeanine Downie, MD and Chicagoland facial plastic surgeon Steve Dayan, MD about what to expect from insurance coverage during the pandemic and how to beef up your policies i
- COVID-19 By the Numbers: April 14 Editionhttps://modernaesthetics.com/news/covid-19-by-the-numbers-april-14-edition-1/2472912/Economic indicators still paint a grim picture, but the medical data suggest the US may be turning the corner in the fight against COVID-19. In fact, the US may have already reached its peak for medical resource utilization associated with COVID-19, according to estimates from the Institute
- FDA Clears Wontech’s Sandro Dual Laserhttps://modernaesthetics.com/news/fda-clears-wontechs-sandro-dual-laser/2472905/The U.S. Food and Drug Administration granted 510 (K) marketing clearance to Wontech’s Sandro Dual, a hybrid Nd:YAG & Alexandrite laser device. In the hybrid mode, by irradiating a short time difference between two wavelengths of 755nm and 1064nm, the laser accurately hits its
- Industry Responds to COVID-19: E.T. Browne Drug Co., RealSelf, HydraFacial, Thrive Causemeticshttps://modernaesthetics.com/news/industry-responds-to-covid-19-dermyoung-coty-leo-pharma/2472903/E.T. Browne Drug Co. The manufacturer of Palmer' Cocoa Butter Formula and Coconut Oil Formula skin and hair care products is now producing medical-grade hand sanitizer to address widespread supply shortages in the wake of COVID-19. Initial production of the disinfectant sanit
- Aaron Burton Named CEO at Scitonhttps://modernaesthetics.com/news/aaron-burton-named-ceo-at-sciton/2472888/Aaron Burton is Sciton Inc.’s new Chief Executive Officer. Aaron has spent the last eight years at Sciton growing the Aesthetic Sales Team, Women’s Health Group, International Sales Team and more recently o
- FDA Sets November PDUFA Date for DaxibotulinumtoxinA from Revancehttps://modernaesthetics.com/news/fda-sets-november-pdufa-date-for-daxibotulinumtoxina-from-revance/2472880/FDA has accepted the Biologics License Application (BLA) for DaxibotulinumtoxinA for Injection (DAXI) in the treatment of moderate to severe glabellar (frown) lines, Revance reports. The FDA set an action date of November 25, 2020 under the Prescription Drug User Fee Act (PDUFA) VI program.
- Candela Launches Exceed Medical Microneedling Systemhttps://modernaesthetics.com/news/candela-launches-exceed-medical-microneedling-system/2472878/Candela Corporation has entered into an exclusive collaboration agreement with MT.DERM GmbH for the commercialization of MT.DERM's medical microneedling products. Under the terms of the agreement, Candela will commercialize the Exceed medical microneedling system globally, with a first launch
- Cynosure News: Todd Tillemans Named New CEOhttps://modernaesthetics.com/news/cynosure-news-todd-tillemans-named-new-ceo/2472869/Todd Tillemans is the new Chief Executive Officer of Cynosure, LLC. Mr. Tillemans is the former President of Hershey's flagship U.S. business generating more than $6.5 billion in annual sales. Prior to that, he held various leadership positions across Unilever's
- Crown Laboratories Restructures after Acquisitionshttps://modernaesthetics.com/news/crown-laboratories-restructures-after-acquisitions/2472866/Crown Laboratories has restructured its commercial operations business units as it continues to elevate its new “Skin Science for Life” commitment. For the past two years, Crown says it has been dedicated to transforming its Northeast Tennessee operations into a global skinc
- AestheticsWire Exclusive: Meet Allē, Allergan’s Upgraded Patient Loyalty Programhttps://modernaesthetics.com/news/aestheticswire-exclusive-meet-alle-allergans-upgraded-patient-loyalty-program/2472858/Allergan’s Brilliant Distinctions customer loyalty program is getting a facelift in honor of its 2nd decade. The program is smarter, faster and now goes by Allē. It’s much more than a new name, shares Carrie Strom, Allergan’s Senior Vice President o